HPGD and colorectal carcinoma: Additional support for the involvement of altered15-PGDH enzyme activity in CRC development was recently documented in a mouse model of 15-PGDH -/-mouse demonstrating resistance to COX-2-inhibitor celecoxib' prevention of colon tumors [40].